Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.19.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2019
Dec. 31, 2018
CURRENT ASSETS:    
Cash and cash equivalents $ 21,650,000 $ 23,763,000
Marketable securities, at fair value 30,837,000 31,228,000
Royalty receivables, net 774,000 444,000
Other current assets 83,000 112,000
Total Current Assets 53,344,000 55,547,000
OTHER ASSETS:    
Deferred tax assets 233,000 168,000
Patents, net of accumulated amortization 1,959,000 1,989,000
Equity investment 2,445,000 2,541,000
Operating leases right-of-use asset 95,000
Security deposits 21,000 21,000
Total Other Assets 4,753,000 4,719,000
TOTAL ASSETS 58,097,000 60,266,000
CURRENT LIABILITIES:    
Accounts payable 395,000 67,000
Income taxes payable 197,000 197,000
Accrued contingency fees and related costs 198,000 1,136,000
Accrued payroll 68,000 486,000
Operating lease obligations – current 88,000
Other accrued expenses 140,000 175,000
TOTAL CURRENT LIABILITIES 1,086,000 2,061,000
Operating lease obligations 8,000
TOTAL LIABILITIES 1,094,000 2,061,000
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY    
Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at March 31, 2019 and December 31, 2018
Common stock, $0.01 par value; authorized 50,000,000 shares; 23,782,761 and 23,735,927 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively 238,000 237,000
Additional paid-in capital 65,294,000 65,151,000
Accumulated deficit (8,558,000) (7,102,000)
Accumulated other comprehensive income (loss) 29,000 (81,000)
TOTAL STOCKHOLDERS' EQUITY 57,003,000 58,205,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 58,097,000 $ 60,266,000